Sustained response to intravenous alendronate in postmenopausal osteoporosis
- 31 December 1995
- Vol. 17 (6) , 517-520
- https://doi.org/10.1016/8756-3282(95)00400-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The assessment of vertebral deformity: A method for use in population studies and clinical trialsOsteoporosis International, 1993
- Effects of five daily 1 h infusions of alendronate in paget's disease of boneJournal of Bone and Mineral Research, 1992
- Spontaneous Fractures in a Patient Treated with Low Doses of Etidronic Acid (Disodium Etidronate)Drug Safety, 1992
- BisphosphonatesDrugs, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonateJournal of Bone and Mineral Research, 1990
- An evaluation of serum osteocalcin in pacet's disease of bone and its response to diphosphonate treatmentArthritis & Rheumatism, 1988
- Long-Term Follow-up Observations on Treatment in Paget??s Disease of BonePublished by Wolters Kluwer Health ,1987
- Experimental Basis for the Use of Bisphosphonates in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients.Journal of Clinical Investigation, 1981